Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.730 | 2.740 | 0.010 |
Shares | 97.220 | 97.220 | 0.000 |
Bonds | 0.050 | 0.090 | 0.040 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.466 | 20.556 |
Price to Book | 3.894 | 4.182 |
Price to Sales | 3.892 | 2.480 |
Price to Cash Flow | 18.556 | 16.880 |
Dividend Yield | 1.415 | 1.341 |
5 Years Earnings Growth | 15.525 | 13.206 |
Number of long holdings: 60
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 6.23 | 799.90 | +1.61% | |
Thermo Fisher Scientific | US8835561023 | 4.89 | 542.31 | -0.48% | |
J&J | US4781601046 | 4.07 | 142.06 | -0.15% | |
Novartis | CH0012005267 | 3.99 | 91.09 | -0.60% | |
Sanofi | FR0000120578 | 3.41 | 95.61 | -0.72% | |
AbbVie | US00287Y1091 | 3.29 | 175.17 | -1.87% | |
Novo Nordisk B | DK0062498333 | 3.26 | 632.3 | +0.37% | |
UnitedHealth | US91324P1021 | 2.97 | 520.69 | -0.73% | |
IQVIA Holdings | US46266C1053 | 2.84 | 203.27 | -0.51% | |
Lonza Group | CH0013841017 | 2.74 | 554.00 | -0.50% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
FR0013073731 | 707.31M | 3.11 | -0.33 | 5.97 | ||
FR0013446812 | 138.68M | -22.69 | -18.59 | - | ||
FR0013083656 | 46.66M | 0.26 | -4.55 | 4.43 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review